BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27766305)

  • 21. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.
    Gatalica Z
    Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary Cutaneous Mucinous Carcinoma with Extramammary Paget's Disease: Eccrine or Apocrine?
    Oh SJ; Kim YO
    J Pathol Transl Med; 2018 Jul; 52(4):238-242. PubMed ID: 29366305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apocrine carcinoma of the scalp with neck lymph node metastasis: A case report and review of the literature.
    Al-Hakami H; Awad BI; Al-Garni M; Al-Maghrabi HA; Al-Shareef N
    J Family Med Prim Care; 2019 Nov; 8(11):3758-3762. PubMed ID: 31803688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary cutaneous mucinous carcinoma: presence of myoepithelial cells as a clue to the cutaneous origin.
    Qureshi HS; Salama ME; Chitale D; Bansal I; Ma CK; Raju U; Ormsby A; Lee MW
    Am J Dermatopathol; 2004 Oct; 26(5):353-8. PubMed ID: 15365364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of estrogen receptor, progesterone receptor and HER2 results in concurrent ipsilateral samples with invasive breast carcinoma: a retrospective study of 246 biopsies from 119 patients.
    Singh K; Wang Y; Marketkar S; Kalife ET; Steinhoff MM
    Hum Pathol; 2017 Jul; 65():123-132. PubMed ID: 28457730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast.
    Honma N; Takubo K; Akiyama F; Sawabe M; Arai T; Younes M; Kasumi F; Sakamoto G
    Histopathology; 2005 Aug; 47(2):195-201. PubMed ID: 16045781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary cutaneous cribriform apocrine carcinoma: a clinicopathologic and immunohistochemical study of 26 cases of an under-recognized cutaneous adnexal neoplasm.
    Rütten A; Kutzner H; Mentzel T; Hantschke M; Eckert F; Angulo J; Rodríguez Peralto JL; Requena L
    J Am Acad Dermatol; 2009 Oct; 61(4):644-51. PubMed ID: 19751882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apocrine carcinoma of the vulva in a band-like arrangement with inflammatory and telangiectatic metastasis via local lymphatic channels.
    Kiyohara T; Kumakiri M; Kawami K; Kouraba S; Takeuchi A; Sawai T; Lao LM; Ansai S; Hashimoto K
    Int J Dermatol; 2003 Jan; 42(1):71-4. PubMed ID: 12581149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histiocytoid and signet-ring cell carcinoma of the axilla: a type of cutaneous apocrine carcinoma equivalent to histiocytoid lobular carcinoma of the breast?
    Misago N; Shinoda Y; Okawa T; Aoki S; Toda S; Koike K; Narisawa Y
    Clin Exp Dermatol; 2011 Dec; 36(8):874-7. PubMed ID: 21689143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiating breast carcinoma with signet ring features from gastrointestinal signet ring carcinoma: assessment of immunohistochemical markers.
    Hui Y; Wang Y; Nam G; Fanion J; Sturtevant A; Lombardo KA; Resnick MB
    Hum Pathol; 2018 Jul; 77():11-19. PubMed ID: 29317235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extramammary Paget disease is characterized by the consistent lack of estrogen and progesterone receptors but frequently expresses androgen receptor.
    Diaz de Leon E; Carcangiu ML; Prieto VG; McCue PA; Burchette JL; To G; Norris BA; Kovatich AJ; Sanchez RL; Krigman HR; Gatalica Z
    Am J Clin Pathol; 2000 Apr; 113(4):572-5. PubMed ID: 10761460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors.
    Truin W; Roumen RMH; Siesling S; van de Vijver KK; Tjan-Heijnen VCG; Voogd AC
    Breast Cancer Res Treat; 2017 Jul; 164(1):133-138. PubMed ID: 28365833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemically defined subtypes and outcome of apocrine breast cancer.
    Dellapasqua S; Maisonneuve P; Viale G; Pruneri G; Mazzarol G; Ghisini R; Mazza M; Iorfida M; Rotmensz N; Veronesi P; Luini A; Goldhirsch A; Colleoni M
    Clin Breast Cancer; 2013 Apr; 13(2):95-102. PubMed ID: 23245877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast cancer molecular class ERBB2: preponderance of tumors with apocrine differentiation and expression of basal phenotype markers CK5, CK5/6, and EGFR.
    Bhargava R; Beriwal S; Striebel JM; Dabbs DJ
    Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):113-8. PubMed ID: 19801938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological feature and long-term prognosis of apocrine carcinoma of the breast in Japanese women.
    Takeuchi H; Tsuji K; Ueo H; Kano T; Maehara Y
    Breast Cancer Res Treat; 2004 Nov; 88(1):49-54. PubMed ID: 15538045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fine-needle aspiration cytologic features of four special types of breast cancers: mucinous, medullary, apocrine, and papillary.
    Haji BE; Das DK; Al-Ayadhy B; Pathan SK; George SG; Mallik MK; Abdeen SM
    Diagn Cytopathol; 2007 Jul; 35(7):408-16. PubMed ID: 17580344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary signet-ring cell/histiocytoid carcinoma of the eyelid: a clinicopathologic study of 5 cases and review of the literature.
    Requena L; Prieto VG; Requena C; Sarasa JL; Manzano R; Seco M; Rütten A; Kazakov DV; Cerroni L; Kutzner H
    Am J Surg Pathol; 2011 Mar; 35(3):378-91. PubMed ID: 21317710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic pitfalls in fine needle aspiration cytology of atypical apocrine metaplasia in a breast lesion. A case report.
    Gupta D; Wolf JA; Rubenchik IA; Middleton LP
    Acta Cytol; 2002; 46(4):749-52. PubMed ID: 12146046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apocrine carcinoma with signet ring cells and histiocytoid features. A potentially confusing axillary tumor.
    Cameselle-Teijeiro J; Alfonsín-Barreiro N; Allegue F; Caeiro M
    Pathol Res Pract; 1997; 193(10):713-20; discussion 721-22. PubMed ID: 9505264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oestrogen receptor-beta1 but not oestrogen receptor-betacx is of prognostic value in apocrine carcinoma of the breast.
    Honma N; Saji S; Kurabayashi R; Aida J; Arai T; Horii R; Akiyama F; Iwase T; Harada N; Younes M; Toi M; Takubo K; Sakamoto G
    APMIS; 2008 Oct; 116(10):923-30. PubMed ID: 19132986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.